Innate Immune Mechanisms Governing Subclinical Malaria in Children
控制儿童亚临床疟疾的先天免疫机制
基本信息
- 批准号:10460703
- 负责人:
- 金额:$ 73.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:15 year oldATAC-seqAddressAffectAfricaAfrica South of the SaharaAgeAgonistAnopheles GenusAnti-Inflammatory AgentsAreaBinding SitesBiological AssayBiomassBloodBlood specimenCellsChildChromatinChronicClinicalCommunitiesComplexCountyCulicidaeCytokine GeneCytometryDNADNA sequencingDataDevelopmentDiseaseElementsEnhancersEnrollmentEpidemiologyEpigenetic ProcessEquilibriumFeverGene ExpressionGene Expression ProfileGenesGoalsHigh-Throughput Nucleotide SequencingHomeostasisImmuneImmunomodulatorsIn VitroIndividualInfectionInflammation MediatorsInflammatoryInflammatory ResponseInnate Immune ResponseInterferon Type IIInterferonsInterleukin-1 ReceptorsInterleukin-10Interleukin-6KenyaKnowledgeLegal patentLongitudinal cohort studyMalariaMeasurementModificationParasitemiaParasitesPathway interactionsPeripheral Blood Mononuclear CellPlasmaPlasmodium falciparumPopulationProductionProteinsPublic HealthRNA analysisRegulator GenesRegulatory PathwayRegulatory T-LymphocyteResearchRoleSchool-Age PopulationSiteSourceSpecificitySymptomsT-Lymphocyte SubsetsTNF geneTestingTissue-Specific Gene ExpressionToll-like receptorsTransposaseWorkadaptive immunityage groupantagonistchromatin immunoprecipitationcohortcomparison groupcytokineeffector T cellepigenetic markerepigenomeinnate immune mechanismsinnate immune pathwaysinsightmonocytepromoterresponserural areasextranscription factortranscriptome sequencingtransmission processvectorvector mosquito
项目摘要
ABSTRACT
Subclinical (asymptomatic) malaria with Plasmodium falciparum (Pf) is common in children who live in moderate-
to-high transmission areas of sub-Saharan Africa. Although subclinical malaria may be submicroscopic, affected
school-age children (ages 8-15 years) often have positive blood smears that include millions of parasites per mL
of blood. While subclinical malaria is typically attributed to acquired adaptive immunity that tightly controls the Pf
biomass, patent parasitemia (blood smear+) exceeds any reasonable estimate of the pyrogenic threshold. How
is it possible to remain without fever and overt malaria symptoms with patent parasitemia? In contrast to
symptomatic malaria, temporally persistent (chronic) subclinical malaria seems to be maintained by a complex
balance of pro-inflammatory and anti-inflammatory cytokines and immune cells. The scientific premise of this
proposal is that epigenetic modifications of innate immune cells, including blood monocytes (Mo), modulate
inflammatory pathways underlying subclinical malaria. Furthermore, we hypothesize that an immune
homeostasis network involving anti-inflammatory Pf-induced type 1 T regulatory cells (Tr1) and IL-10 as well as
enhanced IL-1RA production suppress innate immune inflammatory pathways. Subclinical malaria is of high
epidemiologic significance as parasitemia persists for months in schoolchildren who serve as the major reservoir
of gametocytes required to sustain Pf transmission to local anopheline vectors. Indeed, it is estimated that ~
60% of new mosquito infections can be attributed to this demographic. To test our hypotheses, we will enroll
Kenyan schoolchildren (ages 8-15) in a longitudinal cohort study to compare and analyze differences in immune
parameters between those with A) chronic subclinical malaria (Pf+ smear at baseline and who remain afebrile
despite repeatedly smear+ x 16 weeks) relative to B) children who develop febrile clinical malaria up to 2 weeks
after an afebrile Pf+ smear. The specificity of immune parameters for chronic Pf exposure in these cohorts will
be interrogated by comparison to age and sex matched children residing in a nearby highlands area where
malaria endemicity is ~ zero. PBMC and isolated Mo from children will be analyzed by RNA-seq to determine
activated gene expression pathways. We will define the differences in immune cell subsets, the transcription
factors that are activated and their effector cytokine expression profiles using mass cytometry (CyTOF). In
addition, we will use chromatin immunoprecipitation (ChIP) DNA sequencing to determine if the epigenomes of
children with chronic subclinical malaria are modified in order to silence proinflammatory genes or conversely,
to activate anti-inflammatory ones. Finally, we will identify and compare by Assay for Transposase-Accessible
Chromatin with high-throughput Sequencing (ATAC-seq) open chromatin sites in key gene expression pathways
in Mo from the comparator groups and align these regions with RNA-seq data from the same child. The
successful completion of this project should give us new and important insights as to the mechanism of
subclinical malaria and how this disease state can be modified to facilitate malaria eradication.
摘要
亚临床(无症状)疟疾与恶性疟原虫(Pf)是常见的儿童谁住在中度-
撒哈拉以南非洲的高传播地区。虽然亚临床疟疾可能是亚微观的,但受影响的
学龄儿童(8 - 15岁)的血涂片通常呈阳性,每毫升中含有数百万个寄生虫
鲜血虽然亚临床疟疾通常归因于获得性适应性免疫,
生物量,寄生虫血症(血涂片+)超过热原阈值的任何合理估计。如何
是否有可能保持没有发烧和明显的疟疾症状与专利寄生虫血症?相比
有症状的疟疾,暂时持续的(慢性)亚临床疟疾似乎是由一种复杂的
促炎和抗炎细胞因子和免疫细胞的平衡。科学的前提是
建议是先天免疫细胞,包括血液单核细胞(Mo)的表观遗传修饰,
亚临床疟疾的炎症途径。此外,我们假设免疫系统
涉及抗炎性Pf-induced 1型T调节细胞(Tr1)和IL-10以及
增强的IL-1RA产生抑制先天免疫炎症途径。亚临床疟疾发病率高,
流行病学意义,因为寄生虫血症在作为主要储存者的学童中持续数月,
的配子体所需的维持Pf传输到本地按蚊载体。事实上,据估计,
60%的新蚊子感染可归因于这一人口。为了验证我们的假设,我们将招募
肯尼亚学龄儿童(8 - 15岁)在一项纵向队列研究中比较和分析免疫差异,
A)慢性亚临床疟疾(基线时Pf+涂片)和保持无发热的患者之间的参数
尽管反复涂片+x 16周)相对于B)发展为发热性临床疟疾长达2周的儿童
在无发热的Pf+涂片之后。这些队列中慢性Pf暴露的免疫参数的特异性将
通过与居住在附近高地地区的年龄和性别匹配的儿童进行比较进行审讯,
疟疾流行率为零。将通过RNA-seq分析来自儿童的PBMC和分离的Mo,以确定
激活基因表达途径。我们将定义免疫细胞亚群的差异,转录
活化的因子及其效应细胞因子表达谱。在
此外,我们将使用染色质免疫沉淀(ChIP)DNA测序,以确定是否表观基因组的
对患有慢性亚临床疟疾的儿童进行修饰以使促炎基因沉默或相反,
来激活抗炎的细胞。最后,我们将通过转座酶活性测定进行鉴定和比较
染色质高通量测序(ATAC-seq)在关键基因表达途径中开放染色质位点
在Mo中,将这些区域与来自同一儿童的RNA-seq数据进行比对。的
这一项目的成功完成将使我们对这一机制有新的重要认识。
亚临床疟疾以及如何改变这种疾病状态以促进消灭疟疾。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Douglas T Golenbock其他文献
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
NALP3 炎性体参与对淀粉样β的固有免疫应答
- DOI:
10.1038/ni.1636 - 发表时间:
2008-07-11 - 期刊:
- 影响因子:27.600
- 作者:
Annett Halle;Veit Hornung;Gabor C Petzold;Cameron R Stewart;Brian G Monks;Thomas Reinheckel;Katherine A Fitzgerald;Eicke Latz;Kathryn J Moore;Douglas T Golenbock - 通讯作者:
Douglas T Golenbock
Adjuvants and their signaling pathways: beyond TLRs
佐剂及其信号通路:超越 TLRs
- DOI:
10.1038/ni1203-1162 - 发表时间:
2003-12-01 - 期刊:
- 影响因子:27.600
- 作者:
Egil Lien;Douglas T Golenbock - 通讯作者:
Douglas T Golenbock
Innate immunity in Alzheimer's disease
阿尔茨海默病中的先天免疫
- DOI:
10.1038/ni.3102 - 发表时间:
2015-02-17 - 期刊:
- 影响因子:27.600
- 作者:
Michael T Heneka;Douglas T Golenbock;Eicke Latz - 通讯作者:
Eicke Latz
Douglas T Golenbock的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Douglas T Golenbock', 18)}}的其他基金
Neisseria gonorrhoeae exploits host interferon epsilon to establish infection in the female urogenital tract
淋病奈瑟菌利用宿主干扰素ε在女性泌尿生殖道中建立感染
- 批准号:
10655520 - 财政年份:2021
- 资助金额:
$ 73.77万 - 项目类别:
Neisseria gonorrhoeae exploits host interferon epsilon to establish infection in the female urogenital tract
淋病奈瑟菌利用宿主干扰素ε在女性泌尿生殖道中建立感染
- 批准号:
10317367 - 财政年份:2021
- 资助金额:
$ 73.77万 - 项目类别:
Neisseria gonorrhoeae exploits host interferon epsilon to establish infection in the female urogenital tract
淋病奈瑟菌利用宿主干扰素ε在女性泌尿生殖道中建立感染
- 批准号:
10435574 - 财政年份:2021
- 资助金额:
$ 73.77万 - 项目类别:
Inflammasome activation in modulation of Alzheimer's Disease by alcohol
酒精调节阿尔茨海默氏病中炎症小体的激活
- 批准号:
10673213 - 财政年份:2020
- 资助金额:
$ 73.77万 - 项目类别:
Inflammasome activation in modulation of Alzheimer's Disease by alcohol
酒精调节阿尔茨海默氏病中炎症小体的激活
- 批准号:
10471334 - 财政年份:2020
- 资助金额:
$ 73.77万 - 项目类别:
Inflammasome activation in modulation of Alzheimer's Disease by alcohol
酒精调节阿尔茨海默氏病中炎症小体的激活
- 批准号:
10264088 - 财政年份:2020
- 资助金额:
$ 73.77万 - 项目类别:
Mechanisms of type I IFN enhanced gonococcal infection
I型干扰素增强淋球菌感染的机制
- 批准号:
9979327 - 财政年份:2020
- 资助金额:
$ 73.77万 - 项目类别:
Role of inflammasomes in Alzheimer's Disease
炎症小体在阿尔茨海默病中的作用
- 批准号:
10167924 - 财政年份:2018
- 资助金额:
$ 73.77万 - 项目类别:
相似国自然基金
基于ATAC-seq与DNA甲基化测序探究染色质可及性对莲两生态型地下茎适应性分化的作用机制
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
利用ATAC-seq联合RNA-seq分析TOP2A介导的HCC肿瘤细胞迁移侵
袭的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
- 批准号:62302218
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
- 批准号:82001520
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
靶向治疗动态调控肺癌细胞DNA可接近性的ATAC-seq分析
- 批准号:81802809
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
运用ATAC-seq技术分析染色质可接近性对犏牛初级精母细胞基因表达的调控作用
- 批准号:31802046
- 批准年份:2018
- 资助金额:27.0 万元
- 项目类别:青年科学基金项目
基于ATAC-seq和RNA-seq研究CWIN调控采后番茄果实耐冷性作用机制
- 批准号:31801915
- 批准年份:2018
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
基于ATAC-seq高精度预测染色质相互作用的新方法和基于增强现实的3D基因组数据可视化
- 批准号:31871331
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
相似海外基金
Project #2 Integrated single-nucleus multi-omics (ATAC-seq+RNA-seq or chromatin accessibility + RNA-seq) of human TGs
项目
- 批准号:
10806548 - 财政年份:2023
- 资助金额:
$ 73.77万 - 项目类别:
A transposase system for integrative ChIP-exo and ATAC-seq analysis at single-cell resolution
用于单细胞分辨率综合 ChIP-exo 和 ATAC-seq 分析的转座酶系统
- 批准号:
10210424 - 财政年份:2018
- 资助金额:
$ 73.77万 - 项目类别:
EAPSI: Developing Single Nucleus ATAC-seq to Map the Ageing Epigenome
EAPSI:开发单核 ATAC-seq 来绘制衰老表观基因组图谱
- 批准号:
1714070 - 财政年份:2017
- 资助金额:
$ 73.77万 - 项目类别:
Fellowship Award
A cloud-based learning module to analyze ATAC-seq and single cell ATAC-seq data
基于云的学习模块,用于分析 ATAC-seq 和单细胞 ATAC-seq 数据
- 批准号:
10558379 - 财政年份:2001
- 资助金额:
$ 73.77万 - 项目类别:














{{item.name}}会员




